Collectively, these findings elucidated a novel regulatory axis involving CAFs, exosomal COX4I2, and ferroptosis, offering a promising therapeutic target for disrupting stromal support mechanisms in osteosarcoma. The gene discussed is COX4I2; the disease is osteosarcoma.